Pain Management in Acute Gout: NSAIDs or COX-2 Inhibitors?
A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?
©htpix/stock.adobe.com
A 2020 meta-analysis published in BMJ Open assessed the comparative clinical efficacy of traditional non-selective NSAIDs and selective COX-2 inhibitors in patients with acute gout.
The main outcome measures included were mean change in pain Visual Analogue Scale score and 5-point Likert scale score on days 2–8. All of the following questions and answers are based on findings from this meta-analysis.
Do the analysis results match your experience in clinical practice?
Note: the meta-analysis did not include naproxen for comparisons, due to a lack of clinical trials. The analysis also did not include comparison to colchicine or corticosteroids.
1. Which of the following offers a clear advantage in terms of pain scores in acute gout?
A. Etoricoxib
B. Celecoxib
C. Meloxicam
D. Ibuprofen
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
